Invited ReviewMood and gut feelings
Introduction
Psychiatric disorders which are on the increase globally, already rank among the leading causes of disability, and are expected to take over first place within the next few years. Indeed, the World Health Report 2001 cites depression as causing the largest amount of disability worldwide (disability adjusted life years-DALYs) and in 2004 Ustun et al. stated that depression was the fourth leading cause of disease burden but represents the largest amount of non-fatal burden globally (WHO, 2001, Ustun et al., 2004). In addition, there is extensive epidemiological evidence to support the view that significant co-morbidity exists between many chronic medical and psychiatric diseases, especially mood disorders (Moussavi et al., 2007, Van Lieshout et al., 2008). The severity and prognosis of medical illness are substantially affected by the presence or absence of co-morbid depression. For example, depression is a significant risk factor for myocardial infarction (Rosengren et al., 2004) and its presence at the time of infarction predicts a greater than threefold increase in likely death from cardiac causes within 5 years (Lesperance et al., 2002). Individuals with depression also have higher rates of obesity, hypertension, dyslipidemia, metabolic syndrome and diabetes than the general population (Chengappa et al., 2004, Heiskanen et al., 2006).
Therefore, a better understanding of the biology of mood disorders is critically important not only to provide more effective treatment to patients with these conditions but also to those with chronic co-morbid medical illnesses.
Recent dramatic scientific advances in molecular biology and their application to the study of the human genome have produced much evidence to support the genetic basis of a number of chronic diseases. However, the results are fraught with difficulty of interpretation as well as the knowledge that most of these diseases are polygenic in origin. Indeed the solution to some of the conundra of causation of chronic diseases may lie in greater understanding of the consequences of gene-environment interactions (Cooper, 2003). As a result, the field of epigenetics is expanding explosively and is being applied to psychiatric disorders (Mill and Petronis, 2007, Tsankova et al., 2007).
We believe that one of the most significant areas that need to be investigated in terms of potential environmental factors contributing to both mood disorders and chronic diseases is the external milieu of microbes found in the intestine. In this review we highlight the evidence that is coming together to support the contention that the gut microbiome may be playing a role in neuronal development and plasticity, modulating pain perception and even behavior. This fertile area for exploratory research may shed some light on the causes of, and eventually offer novel therapeutic approaches to, mood disorders and the medical disorders that are often co-morbidly associated with them. (Fig. 1).
Section snippets
The gut microbiome
The human gut is sterile at birth. Immediately after birth, it is colonized by numerous types of microorganisms. In the first weeks of life, tremendous temporal and inter-individual variation is evident in the infant’s microbial populations (microbiome). By 1 year of age, while babies retain their unique bacterial profiles, these converge toward a profile characteristic of the adult individual gastrointestinal tract (Palmer et al., 2007). While significant changes may occur in things such as
Immune system and cytokines
The development of the intestinal immune system is largely dependent upon exposure to microorganisms (Umesaki et al., 1995). In germ free (GF) animals which have scanty lymphoid tissue and constitutively and are almost devoid of immune activity (Talham et al., 1999), association with certain individual selected microorganisms has been shown to be effective in generation of the complete repertoire of immune function. For example, colonization with the segmented filamentous bacterium was able to
Role of gut microbiota in host metabolism
It is widely recognized that gut microbes are responsible for an enormous array of metabolic activities that include effects on the digestion of food and the production of a host of biologically active substances. Recent data suggest that gut microbiota also affect host metabolism, have an impact on energy storage and may therefore be an important environmental factor in the development of obesity and type 2 diabetes (Turnbaugh et al., 2006). These observations are relevant to the
Microbiota and the nervous system
While the role of gut microbiota in influencing brain and nerve function may not be strikingly obvious at first glance, recent research in several different disciplinary fields suggests that intestinal microbiota may be intimately and constitutively involved in modulation of both central and peripheral nerve function. A good example of this influence can be found in clinical medicine in hepatic failure. Hepatic encephalopathyis a commonly encountered medical condition consequent to hepatic
Possible pathways involved in this signaling
The exact mechanisms whereby gut bacteria-induced local changes in gut epithelium and the enteric nervous system communicate with the brain and possibly alter its function and activity, remain to be elucidated. The underlying pathways are highly complex, and it is unlikely that only one common pathway or series of molecules is involved. Two possible pathways we feel may be implicated, however, are reviewed below.
Microbe cell wall constituents
Many different microorganisms may have constitutive and modulatory effects on neuronal function. Commensal microbiota are also being widely consumed by the general public in the form of probiotics. Ingestion of Saccharomyces boulardii, one of these probiotic organisms, has been shown to alter the distribution of the regulatory calcium binding molecule calbindin in the enteric nervous system of conventional pigs (Kamm et al., 2004). The question thus arises as to any common mechanisms of action
Conclusions and perspectives
It is rapidly becoming apparent that the gut microbiome plays a major role in the development and regulation of metabolic systems such as those governing energy production and fat metabolism, neuroendocrine systems such as the HPA axis and the development and function of the immune system. Moreover, evidence is beginning now to accumulate suggesting that intestinal commensals may also be involved in neural development both peripherally in the enteric nervous system and centrally in the brain,
Acknowledgment
We gratefully acknowledge the contribution of the Giovanni and Concetta Guglietti Foundation to some of the research conducted at the Brain-Body Institute.
References (96)
The blood–brain barrier in psychoneuroimmunology
Immunol. Allergy Clin. North Am.
(2009)- et al.
Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood–brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide
Neuroscience
(2006) - et al.
Depression and cortisol responses to psychological stress: a meta-analysis
Psychoneuroendocrinology
(2005) - et al.
The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease
Gastroenterology
(2009) - et al.
The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat
J Psychiatr Res.
(2008) - et al.
Microbial endocrinology: how stress influences susceptibility to infection
Trends Microbiol.
(2008) - et al.
Brain response to cecal infection with Campylobacter jejuni: analysis with Fos immunohistochemistry
Brain Behav. Immun.
(2004) - et al.
Polyamines and their metabolizing enzymes in human frontal cortex and hippocampus: preliminary measurements in affective disorders
Biol. Psychiatry
(1995) - et al.
Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni
Brain Behav. Immun.
(2005) - et al.
Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior
Brain Behav. Immun.
(2008)
Biological basis of the behavior of sick animals
Neurosci. Biobehav. Rev.
Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy
J. Affect. Disord.
Short-chain fatty acids in germfree mice and rats
J. Nutr.
Evolution of cell-cell signaling in animals: did late horizontal gene transfer from bacteria have a role?
Trends Genet.
Influence of probiotic supplemented infant formula on composition of plasma lipids in atopic infants
J. Nutr. Biochem.
Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria
Physiol. Behav.
Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium
Physiol. Behav.
Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders
Behav. Brain Res.
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
Lancet
Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles
Gastroenterology
Brain-immune communication pathways
Brain Behav. Immun.
Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case control study
Lancet
Hydrogen sulfide is a novel prosecretory neuromodulator in the Guinea-pig and human colon
Gastroenterology
Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse
Biol. Psychiatry
Stress and gut microbiota: does postnatal microbial colonization program the hypothalamic–pituitary–adrenal system for stress response?
Int. Congr. Ser.
Effects of intraduodenal injection of Lactobacillus johnsonii La1 on renal sympathetic nerve activity and blood pressure in urethane-anesthetized rats
Neurosci. Lett.
Increased rates of obesity in first-presentation adults with mood disorders over the course of four-year follow-up
J. Affect. Disord.
Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood–brain barrier
Exp. Neurol.
Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications
J. Clin. Endocrinol. Metab.
Commensal microbiota is fundamental for the development of inflammatory pain
Proc. Natl. Acad. Sci. USA
Cytokines, stress and depressive illness: brain-immune interactions
Ann. Med.
The gut microbiota as an environmental factor that regulates fat storage
Proc. Natl. Acad. Sci. USA
Major depressive disorder
N. Engl. J. Med.
Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids
Br. J. Nutr.
Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy
Am. J. Psychiatry
Pathophysiology of hypercortisolism in depression
Acta Psychiatr. Scand. Suppl.
The prevalence of the metabolic syndrome in patients with schizoaffective disorder-bipolar subtype
Bipolar Disord.
The QseC sensor kinase: a bacterial adrenergic receptor
Proc. Natl. Acad. Sci. USA
Gene-environment interactions and the etiology of common complex disease
Ann. Intern. Med.
From inflammation to sickness and depression: when the immune system subjugates the brain
Nat. Rev. Neurosci.
The d-alanine content of lipoteichoic acid is crucial for Lactobacillus plantarum-mediated protection from visceral pain perception in a rat colorectal distension model
Neurogastroenterol. Motil.
Obesity as a correlate of outcome in patients with bipolar I disorder
Am. J. Psychiatry
Lyme disease: a neuropsychiatric illness
Am. J. Psychiatry
Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice
Am. J. Respir. Crit. Care Med.
Gastrointestinal microbiology enters the metagenomics era
Curr. Opin. Gastroenterol.
Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry
J. Clin. Psychiatry
Overview of the brain polyamine-stress-response: regulation, development, and modulation by lithium and role in cell survival
Cell. Mol. Neurobiol.
Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids
Proc. Natl. Acad. Sci. USA
Cited by (355)
Adjunct therapy with probiotics for depressive episodes of bipolar disorder type Ⅰ: A randomized placebo-controlled trial
2023, Journal of Functional FoodsDual-parameter cell biosensor for real-time monitoring of effects of propionic acid on neurons
2023, Biosensors and Bioelectronics